Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 14 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 1 institution in 1 country.
Guillermo Rodríguez-AlonsoDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.
Juan Toledo-MarcosDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.ORCID 0009-0000-3857-3873
Lara Serrano-AguirreDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.ORCID 0000-0002-3436-0237
Carlos RumayorDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.
Beatriz PaseroDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.
Aida FloresDepartment of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.ORCID 0000-0001-7465-6377
Ana SaboridoDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.ORCID 0000-0002-9375-6215
Pilar HoyosDepartment of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.
María J HernáizDepartment of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.ORCID 0000-0003-3897-1104
Isabel de la MataDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.ORCID 0000-0002-6637-2451
Miguel ArroyoDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid (UCM), E-28040 Madrid, Spain.ORCID 0000-0002-1593-9817
Universidad Complutense de Madrid · ES
Funding
Ministerio de Ciencia e Innovación PDC2022-133817-I00Ministerio de Ciencia e Innovación RTI2018-096037B-I00Ministerio de Ciencia e Innovación TED2021-130430B-C21Ministerio de Ciencia e Innovación TED2021-131462B-I00
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.